Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion

Medicine (United States)

Volumn 94, Issue 3, 2015, Pages e396-

  Zhong, Jian Hong ^a   Rodríguez, A Chapin ^a,b   Ke, Yang ^c   Wang, Yan Yan ^a   Wang, Lin ^c   Li, Le Qun ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b Department of Research Creaducate Enterprises Ltd   (Hong Kong)

^c KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL ABSCESS; ARTICLE; ASCITES; ASIAN; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; ETHNICITY; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER RESECTION; MAJOR CLINICAL STUDY; MULTIPLE CANCER; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; TUMOR INVASION; TUMOR VOLUME; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; MORTALITY; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; SURVIVAL RATE; TREATMENT OUTCOME;

CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84922295555     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000396     Document Type: Article

References (105)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003; 362: 1907-1917
3. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53: 1020-1022
4. European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. EASLEORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012; 56: 908-943
5. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334: 693-699
6. Torzilli G, Belghiti J, Kokudo N, et al. Reply to the letter to the editor entitled ''a snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? an observational study of the HCC East-West Study Group'': when the study setting ''ignores'' the patients. Ann Surg. 2013[Epub ahead of print
7. Torzilli G, Belghiti J, Kokudo N, et al. Reply to the letter to the editor titled ''dissecting EASL/AASLD recommendations with a more careful knife: a comment on 'surgical misinterpretation' of the BCLC staging system'': real misinterpretation or lack of clarity within the BCLC? Ann Surg. 2013[Epub ahead of print
8. Torzilli G, Belghiti J, Kokudo N, et al A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg. 2013; 257: 929-937
9. Zhong JH, Ke Y, Gong WF, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg. 2014; 260: 329-340
10. Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008; 134: 1908-1916
11. Zhong JH, Xiang BD, Gong WF, et al. Comparison of long-Term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization. PLoS One. 2013; 8: e68193
12. Livraghi T, Brambilla G, Carnaghi C, et al. Is it time to reconsider the BCLC/AASLD therapeutic flow-chart? J Surg Oncol. 2010; 102: 868-876
13. Arii S, Sata M, Sakamoto M, et al. Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res. 2010; 40: 667-685
14. Lim KC, Chow PK, Allen JC, et al. Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg. 2012; 99: 1622-1629
15. Abdel-Wahab M, Sultan A, el-Ghawalby A, et al. Is resection for large hepatocellular carcinoma in cirrhotic patients beneficial? Study of 38 cases. Hepatogastroenterology. 2001; 48: 757-761
16. Allemann P, Demartines N, Bouzourene H, et al. Long-Term outcome after liver resection for hepatocellular carcinoma larger than 10 cm. World J Surg. 2013; 37: 452-458
17. Ariizumi S, Kotera Y, Takahashi Y, et al. Impact of hepatectomy for huge solitary hepatocellular carcinoma. J Surg Oncol. 2013; 107: 408-413
18. Chang WT, Kao WY, Chau GY, et al. Hepatic resection can provide long-Term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection? Surgery. 2012; 152: 809-820
19. Chen XP, Qiu FZ, Wu ZD, et al. Chinese experience with hepatectomy for huge hepatocellular carcinoma. Br J Surg. 2004; 91: 322-326
20. Cheng CH, Yu MC, Wu TH, et al. Surgical resection of centrally located large hepatocellular carcinoma. Chang Gung Med J. 2012; 35: 178-191
21. Chirica M, Scatton O, Massault PP, et al. Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery? Arch Surg. 2008; 143: 538-543discussion 43
22. Cho YB, Lee KU, Lee HW, et al. Outcomes of hepatic resection for a single large hepatocellular carcinoma. World J Surg. 2007; 31: 795-801
23. Choi GH, Han DH, Kim DH, et al. Outcome after curative resection for a huge (or'10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification. Am J Surg. 2009; 198: 693-701
24. Delis SG, Bakoyiannis A, Tassopoulos N, et al. Hepatic resection for hepatocellular carcinoma exceeding Milan criteria. Surg Oncol. 2010; 19: 200-207
25. Galun DA, Bulajic P, Zuvela M, et al. Is there any benefit from expanding the criteria for the resection of hepatocellular carcinoma in cirrhotic liver? Experience from a developing country. World J Surg. 2012; 36: 1657-1665
26. Hanazaki K, Kajikawa S, Shimozawa N, et al. Hepatic resection for large hepatocellular carcinoma. Am J Surg. 2001; 181: 347-353
27. Ho MC, Huang GT, Tsang YM, et al. Liver resection improves the survival of patients with multiple hepatocellular carcinomas. Ann Surg Oncol. 2009; 16: 848-855
28. Hsu CY, Hsia CY, Huang YH, et al. Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis. Ann Surg Oncol. 2012; 19: 842-849
29. Huang JF, Wu SM, Wu TH, et al. Liver resection for complicated hepatocellular carcinoma: challenges but opportunity for long-Term survivals. J Surg Oncol. 2012; 106: 959-965
30. Ikai I, Arii S, Okazaki M, et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2007; 37: 676-691
31. Lee SG, Hwang S, Jung JP, et al. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. Br J Surg. 2007; 94: 320-326
32. Liau KH, Ruo L, Shia J, et al. Outcome of partial hepatectomy for large (10 cm) hepatocellular carcinoma. Cancer. 2005; 104: 1948-1955
33. Lin CT, Hsu KF, Chen TW, et al. Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice? World J Surg. 2010; 34: 2155-2161
34. Liu CL, Fan ST, Cheung ST, et al. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg. 2006; 244: 194-203
35. Liu CL, Fan ST, Lo CM, et al. Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg. 2000; 232: 25-31
36. Luo J, Peng ZW, Guo RP, et al. Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis. Radiology. 2011; 259: 286-295
37. Mok KT, Wang BW, Lo GH, et al. Multimodality management of hepatocellular carcinoma larger than 10 cm. J Am Coll Surg. 2003; 197: 730-738
38. Nagano Y, Tanaka K, Togo S, et al. Efficacy of hepatic resection for hepatocellular carcinomas larger than 10 cm. World J Surg. 2005; 29: 66-71
39. Ng KK, Vauthey JN, Pawlik TM, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol. 2005; 12: 364-373
40. Ng KM, Yan TD, Black D, et al. Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma. HPB (Oxford). 2009; 11: 311-320
41. Pandey D, Lee KH, Wai CT, et al. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol. 2007; 14: 2817-2823
42. Poon RT, Fan ST, Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg. 2002; 194: 592-602
43. Ramacciato G, Mercantini P, Petrucciani N, et al. Does surgical resection have a role in the treatment of large or multinodular hepatocellular carcinoma? Am Surg. 2010; 76: 1189-1197
44. Ruzzenente A, Capra F, Pachera S, et al. Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients. J Gastrointest Surg. 2009; 13: 1313-1320
45. Schiffman SC, Woodall CE, Kooby DA, et al. Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysis. J Surg Oncol. 2010; 101: 105-110
46. Shah SA, Wei AC, Cleary SP, et al. Prognosis and results after resection of very large (or'10 cm) hepatocellular carcinoma. J Gastrointest Surg. 2007; 11: 589-595
47. Shimada K, Sakamoto Y, Esaki M, et al. Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10 cm or larger in diameter. Langenbecks Arch Surg. 2008; 393: 521-526
48. Shrager B, Jibara GA, Tabrizian P, et al. Resection of large hepatocellular carcinoma (/'10 cm): a unique western perspective. J Surg Oncol. 2013; 107: 111-117
49. Taniai N, Yoshida H, Tajiri T. Adaptation of hepatectomy for huge hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2008; 15: 410-416
50. Truant S, Boleslawski E, Duhamel A, et al. Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection. Eur J Surg Oncol. 2012; 38: 1189-1196
51. Wakabayashi H, Ushiyama T, Ishimura K, et al. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions. J Surg Oncol. 2003; 82: 98-103
52. Wang BW, Mok KT, Liu SI, et al. Is hepatectomy beneficial in the treatment of multinodular hepatocellular carcinoma? J Formos Med Assoc. 2008; 107: 616-626
53. Wang J, Xu LB, Liu C, et al. Prognostic factors and outcome of 438 Chinese patients with hepatocellular carcinoma underwent partial hepatectomy in a single center. World J Surg. 2010; 34: 2434-2441
54. Wang JH, Changchien CS, Hu TH, et al. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma: Survival analysis of 3892 patients. Eur J Cancer. 2008; 44: 1000-1006
55. Yamashita Y, Taketomi A, Shirabe K, et al. Outcomes of hepatic resection for huge hepatocellular carcinoma (/'10 cm in diameter). J Surg Oncol. 2011; 104: 292-298
56. Yang JM, Kan T, Chen H, et al. Hepatectomy in the treatment of very big primary liver cancer: report of 86 cases. Hepatobiliary Pancreat Dis Int. 2002; 1: 42-45
57. Yang LY, Fang F, Ou DP, et al. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg. 2009; 249: 118-123
58. Yin L, Li H, Li AJ, et al. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT. J Hepatol. 2014; 61: 82-88
59. Young AL, Malik HZ, Abu-Hilal M, et al. Large hepatocellular carcinoma: time to stop preoperative biopsy. J Am Coll Surg. 2007; 205: 453-462
60. Zhou L, Rui JA, Wang SB, et al. Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation grade. Eur J Surg Oncol. 2011; 37: 521-525
61. Zhou XD, Tang ZY, Ma ZC, et al. Surgery for large primary liver cancer more than 10 cm in diameter. J Cancer Res Clin Oncol. 2003; 129: 543-548
62. Ban D, Shimada K, Yamamoto Y, et al. Efficacy of a hepatectomy and a tumor thrombectomy for hepatocellular carcinoma with tumor thrombus extending to the main portal vein. J Gastrointest Surg. 2009; 13: 1921-1928
63. Chen JS, Wang Q, Chen XL, et al. Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis. J Surg Res. 2012; 175: 243-250
64. Chen XP, Qiu FZ, Wu ZD, et al. Effects of location and extension of portal vein tumor thrombus on long-Term outcomes of surgical treatment for hepatocellular carcinoma. Ann Surg Oncol. 2006; 13: 940-946
65. Fan J, Zhou J, Wu ZQ, et al. Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol. 2005; 11: 1215-1219
66. Huang J, Hernandez-Alejandro R, Croome KP, et al. Hepatic resection for huge (15 cm) multinodular HCC with macrovascular invasion. J Surg Res. 2012; 178: 743-750
67. Inoue Y, Hasegawa K, Ishizawa T, et al. Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma? Surgery. 2009; 145: 9-19
68. Le Treut YP, Hardwigsen J, Ananian P, et al. Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature A European case-control series. J Gastrointest Surg. 2006; 10: 855-862
69. Liang LJ, Hu WJ, Yin XY, et al. Adjuvant intraportal venous chemotherapy for patients with hepatocellular carcinoma and portal vein tumor thrombi following hepatectomy plus portal thrombectomy. World J Surg. 2008; 32: 627-631
70. Ohkubo T, Yamamoto J, Sugawara Y, et al. Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg. 2000; 191: 657-660
71. Pawlik TM, Poon RT, Abdalla EK, et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery. 2005; 137: 403-410
72. Peng B, Liang L, He Q, et al. Surgical treatment for hepatocellular carcinoma with portal vein tumor thrombus. Hepatogastroenterology. 2006; 53: 415-419
73. Peng ZW, Guo RP, Zhang YJ, et al. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Cancer. 2012; 118: 4725-4736
74. Poon RT, Fan ST, Ng IO, et al. Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification. Ann Surg. 2003; 237: 376-383
75. Roayaie S, Jibara G, Taouli B, et al. Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol. 2013; 20: 3754-3760
76. Shi J, Lai EC, Li N, et al. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus. Ann Surg Oncol. 2010; 17: 2073-2080
77. Tang QH, Li AJ, Yang GM, et al. Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study. World J Surg. 2013; 37: 1362-1370
78. Wang JH, Kuo YH, Wang CC, et al. Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C. Dig Liver Dis. 2013; 45: 510-515
79. Wu CC, Hsieh SR, Chen JT, et al An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation. Arch Surg. 2000; 135: 1273-1279
80. Zhou J, Tang ZY, Wu ZQ, et al. Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases. Hepatogastroenterology. 2006; 53: 275-280
81. Tsoulfas G, Mekras A, Agorastou P, et al. Surgical treatment for large hepatocellular carcinoma: does size matter? ANZ J Surg. 2012; 82: 510-517
82. Truty MJ, Vauthey JN. Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique. Ann Surg Oncol. 2010; 17: 1219-1225
83. Ramacciato G, D'Angelo F, Baldini R, et al. Hepatocellular carcinomas and primary liver tumors as predictive factors for postoperative mortality after liver resection: a meta-Analysis of more than 35, 000 hepatic resections. Am Surg. 2012; 78: 456-467
84. Yanaga K. Current status of hepatic resection for hepatocellular carcinoma. J Gastroenterol. 2004; 39: 919-926
85. Ohishi W, Fujiwara S, Cologne JB, et al. Risk factors for hepatocellular carcinoma in a Japanese population: a nested casecontrol study. Cancer Epidemiol Biomarkers Prev. 2008; 17: 846-854
86. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003; 37: 429-442
87. Lok AS, Seeff LB, Morgan TR, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009; 136: 138-148
88. Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010; 4: 439-474
89. Kudo M, Izumi N, Kokudo N, et al. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis. 2011; 29: 339-364
90. Poon D, Anderson BO, Chen LT, et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009; 10: 1111-1118
91. Ministry of Health of the People's Republic of China. Clinical Guidelines of Primary Liver Cancer (2011 version). Zhonghua Gan Zang Bing Za Zhi. 2012; 20: 419-426
92. Llovet JM, Fuster J, Bruix J. Intention-To-Treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999; 30: 1434-1440
93. Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996; 111: 1018-1022
94. Capussotti L, Ferrero A, Vigano L, et al. Portal hypertension: contraindication to liver surgery? World J Surg. 2006; 30: 992-999
95. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005; 42: 1208-1236
96. Chen XP, Qiu FZ, Wu ZD, et al. Long-Term outcome of resection of large hepatocellular carcinoma. Br J Surg. 2006; 93: 600-606
97. Andreou A, Vauthey JN, Cherqui D, et al. Improved long-Term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg. 2013; 17: 66-77discussion 77
98. Zhang ZM, Guo JX, Zhang ZC, et al. Therapeutic options for intermediate-Advanced hepatocellular carcinoma. World J Gastroenterol. 2011; 17: 1685-1689
99. Abdalla EK, Denys A, Hasegawa K, et al. Treatment of large and advanced hepatocellular carcinoma. Ann Surg Oncol. 2008; 15: 979-985
100. Ku Y, Iwasaki T, Tominaga M, et al. Reductive surgery plus percutaneous isolated hepatic perfusion for multiple advanced hepatocellular carcinoma. Ann Surg. 2004; 239: 53-60
101. Wang JH, Lin G, Yan ZP, et al. Stage II surgical resection of hepatocellular carcinoma after TAE: a report of 38 cases. World J Gastroenterol. 1998; 4: 133-136
102. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012; 379: 1245-1255
103. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005; 25: 181-200
104. Torzilli G. Surgical technique: new advancements for expanding indications and safety: the Western experience. J Hepatobiliary Pancreat Sci. 2010; 17: 394-398
105. Torzilli G, Donadon M, Marconi M, et al. Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis. Arch Surg. 2008; 143: 1082-1090